Methods of treating inflammatory diseases, e.g., diseases associated with inflammatory CD14+/CD16- monocytes, e.g., amyotrophic lateral sclerosis (ALS), stroke, and glaucoma, using compounds such as small molecules and antibodies that target CCR2 or CCL2.
METHODS OF TREATING INFLAMMATORY DISEASES BY TARGETING THE CHEMOATTRACTANT CYTOKINE RECEPTOR 2 (CCR2) OR CHEMOKINE (C-C MOTIF) LIGAND 2 (CCL2)